44
Views
7
CrossRef citations to date
0
Altmetric
Original

Cost-effectiveness of cognitive behavioural therapy and selective serotonin reuptake inhibitors for major depression in children and adolescents

, , , &
Pages 579-591 | Received 29 Aug 2003, Accepted 22 Mar 2004, Published online: 07 Aug 2009

References

  • Sawyer M G, Arney F M, Baghurst P A, et al. The mental health of young people in Australia. Mental Health and Special Programs Branch, Commonwealth Department of Health and Aged Care, Canberra 2000
  • National Health and Medical Research Council. Depression in young people. Clinical practice guidelines. National Health and Medical Research Council, Canberra 1997
  • American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child and Adolescent Psychiatry 1998; 37(Suppl.)
  • Chan R TW, Rey J M, Hazell P L. Clinical practice guidelines for depression in young people: are the treatment recommendations outdated?. Medical Journal of Australia 2002; 177: 448–451
  • Haby M M, Carter R, Mihalopoulos C, Magnus A, Andrews G, Vos T. Assessing Cost-Effectiveness – Mental Health: introduction to the study and methods. Australian and New Zealand Journal of Psychiatry 2004; 38: 569–578
  • Goodyer I M. The depressed child and adolescent2nd edn., I M Goodyer. Cambridge University Press, Cambridge 2001
  • Shoaf T L, Emslie G J, Mayes T L. Childhood depression: diagnosis and treatment strategies in general pediatrics. Pediatric Annals 2001; 30: 130–137
  • Lewinsohn P M, Clarke G N, Seeley J R, Rohde P. Major depression in community adolescents: age at onset, episode duration, and time to recurrence. Journal of the American Academy of Child and Adolescent Psychiatry 1994; 33: 809–818
  • Stouthard M EA, Essink-Bot M, Bonsel G J, et al. Disability weights for diseases in the Netherlands. Department of Public Health, Erasmus University, Rotterdam 1997
  • Australian Bureau of Statistics. Mental health and wellbeing: profile of adults, Australia 1997. Australian Bureau of Statistics, Canberra 1998
  • Ware J E, Jr, Kosinski M, Keller S D. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Medical Care 1996; 34: 220–233
  • Sanderson K, Andrews G, Corry J, Lapsley H. Using the effect size to model change in preference values from descriptive health states. Quality of Life Research 2004; 13, in press
  • Lewinsohn P M, Clarke G N, Hops H, Andrews J. Cognitive-behavioral treatment for depressed adolescents. Behavior Therapy 1990; 21: 385–401
  • Reed M K. Social skills training to reduce depression in adolescents. Adolescence 1994; 29: 293–302
  • Vostanis P, Feehan C, Grattan E, Bickerton W L. Treatment for children and adolescents with depression: lessons from a controlled trial. Clinical Child Psychology and Psychiatry 1996; 1: 199–212
  • Wood A, Harrington R, Moore A. Controlled trial of a brief cognitive-behavioural intervention in adolescent patients with depressive disorder. Journal of Child Psychology and Psychiatry 1996; 37: 737–746
  • Brent D A, Holder D, Kolko D, et al. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Archives of General Psychiatry 1997; 54: 877–885
  • Clarke G N, Rohde P, Lewinsohn P M, Hops H, Steeley J R. Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. Journal of the American Academy of Child and Adolescent Psychiatry 1999; 38: 272–279
  • Rossello J, Bernal G. The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. Journal of Consulting and Clinical Psychology 1999; 67: 734–745
  • Simeon J G, Dinicola V F, Ferguson H B, Copping W. Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1990; 14: 791–795
  • Emslie G J, Rush A J, Weinberg W A, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry 1997; 54: 1031–1037
  • Keller M B, Ryan N D, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry 2001; 40: 762–772
  • Emslie G J, Heiligenstein J H, Wagner K D, et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry 2002; 41: 1205–1215
  • Deeks J J, Altman D G, Bradburn M J. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. Systematic reviews in health care: meta-analysis in context2nd edn., M Egger, G D Smith, G D Altman. BMJ Publishing Group, London 2001; 285–312
  • Palisade Corporation. @RISK [computer program] Risk Analysis Add-in for Microsoft Excel. Palisade Corporation, Newfield, NY 2001, Version 4
  • Gloaguen V, Cottraux J, Cucherat M, Blackburn I. A meta-analysis of the effects of cognitive therapy in depressed patients. Journal of Affective Disorders 1998; 49: 59–72
  • Trindade E, Menon D. Selective serotonin reuptake inhibitors (SSRIs) for major depression. Part 1: Evaluation of the Clinical Literature. Canadian Coordinating Office for Health Technology Assessment, Ottowa 1997
  • Antonuccio D O, Thomas M, Danton W G. A cost-effectiveness analysis of cognitive behavior therapy and fluoxetine (prozac) in the treatment of depression. Behavior Therapy 1997; 28: 187–210
  • Bower P, Byford S, Sibbald B, et al. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: cost effectiveness. British Medical Journal 2000; 321: 1389–1392
  • Frank L, Revicki D A, Sorensen S V, Shih Y T. The economics of selective serotonin reuptake inhibitors in depresssion. CNS Drugs 2001; 15: 59–83
  • Emslie G J, Heiligenstein J H, Hoog S L, et al. Fluoxetine for maintenance of recovery from depression in children and adolescents: a placebo-controlled, randomized clinical trial. Presented at the American Psychiatric Association Annual Meeting 2001, New Orleans, Washington, DC. American Psychiatric Association, 2001
  • Paykel E S, Scott J, Teasdale J D, et al. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Archives of General Psychiatry 1999; 56: 829–835
  • Mental Health and Suicide Prevention Branch. Better outcomes in mental health care initiative. Australian Department of Health and Ageing, Canberra 2002, (Available at: http://www.health.gov.au/hsdd/mentalhe/boimhc/index.htm Last accessed 12 November 2003.)
  • Jureidini J N, Doecke C J, Mansfield P R, Haby M M, Menkes D B, Tonkin A L. Efficacy and safety of antidepressants for children and adolescents. British Medical Journal 2004; 328: 879–883
  • Harrington R, Whittaker J, Shoebridge P, Campbell F. Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder. British Medical Journal 1998; 316: 1559–1563

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.